SEC Form 4 · accession 0001237899-15-000053
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
Nov 2, 2015
Accepted (ET)
Nov 4, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 2, 2015 | S | 13,257 | $580.18 | D | 355,836 | D | |
| Common StockF3 | Nov 3, 2015 | S | 3,985 | $580.23 | D | 351,851 | D | |
| Common Stock | Jan 6, 2015 | G | 511 | $0.00 | D | 155,266 | I | by CLAT |
| Common Stock | Apr 1, 2015 | G | 462 | $0.00 | D | 154,804 | I | by CLAT |
| Common Stock | Jul 1, 2015 | G | 414 | $0.00 | D | 154,390 | I | by CLAT |
| Common Stock | holding | — | — | — | 2,282 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 92,947 | I | by Spouse as Trustee | |
| Common StockF4 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2Represents volume-weighted average price of sales of 13,257 shares of Company stock on November 2, 2015 at prices ranging from $580.00 to $580.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 3,985 shares of Company stock on November 3, 2015 at prices ranging from $580.00 to $580.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 3, 2015 at each separate price.
- F4By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.